Ее только приняли и вряд ли в Европе появится , она только воз признана On May 19, 2022, the World Health Organization (WHO) issued an emergency use listing (EUL) for Convidecia. As of May 2022, Convidecia was available in about ten countries, including Malaysia and Indonesia, as a heterologous booster in China and Argentina. It is also the first adenovirus-vectored vaccine to be included in the heterologous vaccination program in China.
Обсуждают сегодня